Eisai

Eisai, a company established in 1941, is headquartered in Tokyo, Japan, and operates primarily in the pharmaceutical industry with a focus on neurology and oncology. Its neurology segment is dedicated to addressing conditions like Alzheimer's and epilepsy, while oncology is centered on developing cancer treatments. The company has developed significant drugs and brands, including Aricept for Alzheimer's disease, Halaven for breast cancer treatment, Fycompa for epilepsy, and Lenvima, which is used for treating thyroid cancer and various other cancer types. With a presence in multiple countries around the world, Eisai's important markets comprise Japan, the United States, China, and various European countries. The company maintains a global network to ensure its products are distributed and available to patients internationally. (Powered by AI)